Maggie Williams is a Consultant Clinical Scientist, and lead for cardiovascular genetic services at the Bristol Genetics Laboratory at North Bristol Trust, with 30 yrs experience in NHS laboratory genetics.
Her team at BGL developed the first comprehensive high throughput Next Generation Sequencing panel test for Familial Hypercholesterolaemia, now used by multiple lipid teams and cardiologists across England. The team have now provided cost effective gene screening to over 7000 cases facilitating the FH cascade programme initiative, and provide national genomic training to FH nurses and health care professionals.
As Research and Innovation lead she is responsible for academic collaborations and supporting research studies e.g. FAMCAT, and the implementation of innovative technologies to genetic healthcare.
As rare disease lead for the West of England Genomics Medicine Centre and member of the FH GECIP she has been involved in recruiting and data analysis for the 100,000 genomes project, working with Genomics England and NHSE colleagues.
Maggie is a member of the ACGS scientific committee, the BGSM scientific programme committee, and a NEQAS/CEQAS assessor.